J Serwanga
Overview
Explore the profile of J Serwanga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mugaba S, Nakiboneka R, Nanyonjo M, Bugembe-Lule D, Kaddu I, Nanteza B, et al.
Vaccine
. 2014 May;
32(30):3787-95.
PMID: 24837770
Objective: Evaluating HIV-1 specific T-cell response in African populations is sometimes compromised by extensive virus diversity and paucity of non-clade B reagents. We evaluated whether consensus group M (ConM) peptides...
2.
Chen H, Xiang Z, Li Y, Kurupati R, Jia B, Bian A, et al.
J Virol
. 2010 Aug;
84(20):10522-32.
PMID: 20686035
In order to better understand the broad applicability of adenovirus (Ad) as a vector for human vaccine studies, we compared four adenovirus (Ad) vectors from families C (Ad human serotype...
3.
Ndembi N, Lyagoba F, Nanteza B, Kushemererwa G, Serwanga J, Katongole-Mbidde E, et al.
AIDS Res Hum Retroviruses
. 2008 Jun;
24(6):889-95.
PMID: 18544019
To evaluate transmitted HIV-1 drug resistance and study the natural polymorphism in pol of HIV-1 strains of newly diagnosed women attending an antenatal clinic in Uganda we sequenced the protease...
4.
Cao H, Kaleebu P, Hom D, Flores J, Agrawal D, Jones N, et al.
J Infect Dis
. 2003 Mar;
187(6):887-95.
PMID: 12660934
In the first preventative human immunodeficiency virus (HIV) vaccine study to be carried out in Africa, 40 HIV-seronegative Ugandan volunteers were randomly assigned to receive a canarypox vector containing HIV-1...